New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
07:43 EDTAGIOAgios Pharmaceuticals price target raised to $51 from $38 at Leerink
Leerink raised its price target for Agios Pharmaceuticals shares to $51 saying the Phase I data presentation for the AG-221 in IDH2 mutant hematologic malignancies is coming much sooner than expected. The firm keeps an Outperform rating on the stock.
News For AGIO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
08:08 EDTAGIOAgios Pharmaceuticals to present data at 20th Congress of EHA
Subscribe for More Information
May 19, 2015
08:57 EDTAGIOLeerink biotech analyst holds an analyst/industry conference call
Subscribe for More Information
May 18, 2015
07:37 EDTAGIOAgios Pharmaceuticals AG-120 granted FDA Fast Track designation
Subscribe for More Information
May 12, 2015
07:52 EDTAGIOLeerink to hold a tour
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use